1
Circulating Tumor DNA in Primary Mediastinal Large B-cell Lymphoma (PMBL)
Condition(s):Primary Mediastinal Large B-cell LymphomaLast Updated:April 1, 2021Recruiting
Circulating Tumor DNA: 684 Clinical Trials, Page 1 of 69
Hide Studies Not Open or Pending
2
Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA
Condition(s):Hepatocellular CarcinomaLast Updated:May 20, 2022Not yet recruiting
3
Surgery Impact on Circulating Tumor DNA in Pancreatic Cancer
Condition(s):Resectable Pancreatic CancerLast Updated:March 16, 2022Recruiting
4
Detection of Plasma Circulating Tumor DNA in Gastric Cancer
Condition(s):Circulating Tumor DNA (ctDNA); Gastric CancerLast Updated:April 28, 2022Recruiting
5
Clinical Utility of Circulating Tumor DNA in Gastro-Esophageal Cancer
Condition(s):Esophageal Cancer; Gastric CancerLast Updated:October 6, 2020Recruiting
6
Detection of Circulating Tumor DNA in p16- Locally Advanced Head Neck Squamous Cell Carcinoma
Condition(s):Head and Neck Squamous Cell CarcinomaLast Updated:July 30, 2020Recruiting
7
Circulating Tumor DNA in Soft Tissue Sarcoma
Condition(s):Soft Tissue SarcomaLast Updated:April 13, 2021Recruiting
8
CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility
Condition(s):Lung Neoplasms; Lung Cancer; Neoplasm of Lung; Non Small Cell Lung CancerLast Updated:February 18, 2021Completed
9
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
Condition(s):Prostate Cancer; Renal Cell Cancer; Bladder Cancer; Ureter CancerLast Updated:December 13, 2019Recruiting
10
Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
Condition(s):Uveal MelanomaLast Updated:August 7, 2020Completed